3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Colorectal Neoplasms
26
Breast Neoplasms
21
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
15
Head and Neck Neoplasms
13
Rectal Neoplasms
11
Colonic Neoplasms
11
Prostatic Neoplasms
8
Pancreatic Neoplasms
7
Mouth Neoplasms
6
Glioblastoma
6
Neuroblastoma
5
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Triple Negative Breast Neoplasms
4
Recurrence
4
Precancerous Conditions
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Neoplasms
4
Liver Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Gliosarcoma
4
Carcinoma, Hepatocellular
4
Adenomatous Polyposis Coli
4
Sarcoma
3
Interventions
fludarabine
3
Tacrolimus
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
thymoglobulin
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Rituximab
2
Mycophenolic Acid
2
Clofarabine
2
Antilymphocyte Serum
2
trametinib
1
etoposide phosphate
1
dabrafenib
1
cobimetinib
1
Thiotepa
1
Specimen Handling
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Granulocyte Colony-Stimulating Factor
1
Genetic Testing
1
Filgrastim
1
Etoposide
1
Enzyme-Linked Immunosorbent Assay
1
Deferasirox
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Histiocytosis, Langerhans-Cell
×
Celecoxib
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled